CACNA2D2 and colorectal carcinoma: In order to further validate CACNA2D2 as a transcriptional target downstream CDC42 in CRC, we next studied whether its transcriptional silencing was CDC42-dependent in our in vitro SW620 cellular model (Figure 1).